Geneos Wealth Management’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$984K Hold
23,107
– – 0.02% 547
2026
Q1
$935K Sell
23,107
-382
-2% -$16.9K 0.02% 523
2025
Q4
$1.08M Buy
23,489
+747
+3% +$34.1K 0.03% 484
2025
Q3
$1.04M Sell
22,742
-21
-0.1% -$930 0.03% 478
2025
Q2
$939K Buy
22,763
+158
+0.7% +$5.86K 0.02% 550
2025
Q1
$790K Buy
22,605
+40
+0.2% +$1.51K 0.03% 508
2024
Q4
$864K Buy
+22,565
New +$850K 0.03% 452
2022
Q4
– Sell
-13,929
Closed -$306K – 2029
2022
Q3
$306K Sell
13,929
-10,074
-42% -$261K 0.02% 497
2022
Q2
$582K Sell
24,003
-31
-0.1% -$828 0.03% 459
2022
Q1
$732K Sell
24,034
-30
-0.1% -$897 0.03% 445
2021
Q4
$783K Sell
24,064
-1,726
-7% -$54.6K 0.03% 463
2021
Q3
$759K Buy
25,790
+1,732
+7% +$50.6K 0.03% 463
2021
Q2
$665K Sell
24,058
-169
-0.7% -$4.33K 0.03% 481
2021
Q1
$591K Hold
24,227
– – 0.02% 592
2020
Q4
$584K Sell
24,227
-2,760
-10% -$55.2K 0.02% 498
2020
Q3
$469K Buy
26,987
+682
+3% +$12.2K 0.02% 446
2020
Q2
$457K Sell
26,305
-1,296
-5% -$22.8K 0.03% 432
2020
Q1
$416K Sell
27,601
-1,374
-5% -$28.3K 0.03% 409
2019
Q4
$600K Buy
28,975
+31
+0.1% +$618 0.03% 404
2019
Q3
$557K Buy
28,944
+3,249
+13% +$58.8K 0.03% 388
2019
Q2
$438K Buy
25,695
+33
+0.1% +$558 0.03% 438
2019
Q1
$427K Buy
25,662
+42
+0.2% +$654 0.03% 439
2018
Q4
$347K Buy
25,620
+37
+0.1% +$552 0.03% 455
2018
Q3
$406K Buy
25,583
+527
+2% +$8.01K 0.03% 431
2018
Q2
$362K Buy
25,056
+42
+0.2% +$600 0.03% 392
2018
Q1
$348K Sell
25,014
-457
-2% -$6.62K 0.03% 385
2017
Q4
$395K Sell
25,471
-771
-3% -$11.6K 0.04% 362
2017
Q3
$386K Buy
26,242
+36
+0.1% +$505 0.04% 352
2017
Q2
$366K Buy
26,206
+2,142
+9% +$28.8K 0.04% 352
2017
Q1
$313K Buy
24,064
+45
+0.2% +$570 0.03% 380
2016
Q4
$282K Buy
24,019
+955
+4% +$11.6K 0.04% 379
2016
Q3
$289K Buy
23,064
+623
+3% +$7.63K 0.04% 366
2016
Q2
$266K Buy
22,441
+181
+0.8% +$2.17K 0.04% 378
2016
Q1
$270K Buy
+22,260
New +$240K 0.04% 362

Other funds holding BN

Geneos Wealth Management's BN Position: Q2 2026 in Review

Geneos Wealth Management held its Brookfield (BN) position steady in Q2 2026 at 23,107 shares worth $984K. The position accounts for 0.02% of the portfolio, ranked #547.

Geneos Wealth Management first reported a position in BN in Q1 2016 and has held it in 34 quarters since. The position peaked at $1.08M in Q4 2025. 944 funds tracked by Wall St. Rank hold BN as of Q2 2026.

  • Geneos Wealth Management held 23,107 shares of Brookfield worth $984K as of Q2 2026.
  • Geneos Wealth Management left its Brookfield share count unchanged in Q2 2026.
  • Brookfield made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #547 holding.
  • Geneos Wealth Management first reported a position in Brookfield in Q1 2016 and has held it in 34 quarters since.
  • Geneos Wealth Management's Brookfield position peaked at $1.08M in Q4 2025.
  • 944 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.